Stefano Scalera - Concepedia

Author

Stefano Scalera

Istituti di Ricovero e Cura a Carattere Scientifico ORCID

Also Known As

Daniel Colic, S Scalera, S. Scalera, Stefano Scalera

Publications

837

Citations

H-Index

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico Agostino Gemelli University Polyclinic Università Cattolica del Sacro Cuore San Gallicano Hospital Sapienza University of Rome

About

Stefano Scalera is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, lung cancer, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	404
2	Immunology	3	3	322
3	Natural Sciences	2	2	82
4	Cell Biology	2	2	82
5	Cellular Physiology	1	1	60

Stefano Scalera

Publications

594

Citations

H-Index

Page 1

	Year	Citations
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden Daniele Marinelli, Marco Mazzotta, Stefano Scalera, Annals of Oncology MedicineLung AdenocarcinomaImmunologyPathologyCancer Genomics	2020	218
KEAP1 and TP53 Frame Genomic, Evolutionary, and Immunologic Subtypes of Lung Adenocarcinoma With Different Sensitivity to Immunotherapy Stefano Scalera, Marco Mazzotta, Giacomo Corleone, Journal of Thoracic Oncology Tp53 Frame GenomicCancer ImmunosurveillanceLung AdenocarcinomaImmunologyPathology	2021	76
KEAP1-Mutant NSCLC: The Catastrophic Failure of a Cell-Protecting Hub Stefano Scalera, Marco Mazzotta, Clelia Cortile, Journal of Thoracic Oncology Cell RegulationCell DivisionNatural SciencesKeap1-mutant NsclcMolecular Biology	2022	60
The long non-coding RNA NEAT1 is a ΔNp63 target gene modulating epidermal differentiation Claudia Fierro, Veronica Gatti, Veronica La Banca, Nature Communications	2023	34
ΔNp63-Senataxin circuit controls keratinocyte differentiation by promoting the transcriptional termination of epidermal genes Veronica Gatti, Claudia Fierro, Mirco Compagnone, Proceedings of the National Academy of Sciences	2022	29
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma Stefano Scalera, Biagio Ricciuti, Marco Mazzotta, Annals of Oncology Immunotherapy EfficacyLung AdenocarcinomaImmunologyPathologyCancer Genomics	2022	28
SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma Rossella Loria, Valentina Laquintana, Stefano Scalera, Journal of Experimental & Clinical Cancer Research	2022	25
Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51 Gwenola Manic, Martina Musella, Francesca Corradi, Cell Death and Differentiation	2021	23
Che-1/AATF binds to RNA polymerase I machinery and sustains ribosomal RNA gene transcription Cristina Sorino, Valeria Catena, Tiziana Bruno, Nucleic Acids Research Ribosomal RnaMolecular BiologyTumor BiologyTranscriptional RegulationRna Polymerase	2020	22
Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes Marco Mazzotta, Marco Filetti, Mario Occhipinti, Journal for ImmunoTherapy of Cancer	2020	20

Page 1